Most Recent
Aussie designer did not object to Katy Perry’s use of her trade mark, court told
Popstar Katy Perry has rejected claims of trade mark infringment by Sydney-based fashion designer Katie Perry, saying the designer "encouraged or acquiesced to" the singer's use of her name on branded clothing sold in Australia.
Merck wins docs from Wyeth ahead of hearing on reopening Prevnar 13 trial
Merck Sharp & Dohme has emerged victorious in a battle over documents with Wyeth, as the parties gear up for a hearing on Wyeth's request to reopen a trial over three patents for its Prevnar 13 pneumococcal vaccine.
Pfizer may seek stay of Merck vaccine patent case
Global pharmaceutical firm Pfizer is mulling an application to stay a lawsuit by Merck Sharp & Dohme seeking to invalidate a patent related to the blockbuster Prevnar 13 vaccine as it awaits the outcome of similar proceedings in the US.
Claims of stolen docs at heart of new suit against Pfizer over vaccine patent
Merck Sharp & Dohme has claimed ownership of a Pfizer patent related to the blockbuster Prevnar 13 vaccine, after a doctor who moved between the pharmaceutical companies and is listed as an author on the patent allegedly accessed confidential Merck documents before jumping ship to Pfizer.
Yellow Pages maker’s ‘Sensis’ trade mark infringed by rival, court finds
The maker of the Yellow Pages and White Pages directories, Sensis, has won its IP case against a direct marketing company, with a judge ruling the rival's Senses Direct mark was deceptively similar to its mark, both visually and aurally.
ISPs ordered to block sites that ‘rip’ audio from YouTube music videos
The court has ordered Australia's biggest internet service providers to block seven websites from "ripping" audio files from music videos on YouTube, in what the judge described as "industrial scale copyright infringement".
Wyeth slams Merck Sharp & Dohme’s ‘baseless’ invalidity claim in vaccine trial
Pharmaceutical giant Wyeth has accused Merck Sharp & Dohme of a "baseless" patent invalidity case, saying on the second day of trial over the world's best selling vaccine that the development of its patented Prevnar 13 pneumococcal shot was anything but obvious, as its rival contends.
Merck Sharp & Dohme attacks Wyeth’s ‘broad’ patent claims for Prevnar 13 vaccine
A showdown between global pharmaceutical giants over the world's best selling vaccine began Monday in Federal Court, with Merck Sharp & Dohme claiming three patents for Prevnar 13 sold by Pfizer's Wyeth are invalid and that its own vaccine offers greater protection against pneumococcal bacteria.